CDI Lab Earns Grant to Re-engineer Drugs to Combat Emerging Infections
June 23, 2023
![](/-/media/Project/HMH/HMH/CDI/wp-content/uploads/2023/06/Infectious-Disease-TB-and-Non-TB-Scientists-Dartois-and-Dick-Lab-Office-22-scaled.jpg)
A laboratory at the Hackensack Meridian Center for Discovery and Innovation (CDI) has been issued a major grant to repurpose drugs to combat non-tuberculous mycobacteria (NTM), an emerging family of germs naturally found in soil and water and which can be deadly to those with compromised immune systems and pre-existing lung diseases.